In October 2014, Apotex filed a lawsuit against the Canadian government to overturn a ban on importing drugs manufactured in its overseas (India) factories. The government had implemented the ban (that affected 60 drugs and drug ingredients) after public attention was brought to the fact that Health Canada was allowing the drugs' importation despite "Inspectors from the U.S. Food and Drug Administration (FDA) had found that staff at Apotex plants in Bangalore manipulated data, destroyed records and retested samples until they got favourable results" and the US banned imports.